Eli Lilly (LLY) Secures FDA Label Update for Alzheimer’s Disease Treatment

Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the approval by the US Food and Drug Administration of a label update for its once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD).

Eli Lilly (LLY) Secures FDA Label Update for Alzheimer's Disease Treatment

A doctor holding a microscope in front of a laboratory sample of healthcare products.

The new label significantly reduces the incidence of amyloid-related amyloid-related imaging abnormalities with edema/effusion. The company expects the new label update for Kisunla to enhance the way healthcare professionals evaluate treatment options for parents.

“This update underscores our unwavering commitment to patient safety and the advancement of Alzheimer’s disease treatment by potentially mitigating the risk of ARIA-E,” stated Brandy Matthews, MD, FAAN, Lilly’s Vice President of Global & US Medical Affairs for Alzheimer’s Disease.

The FDA has approved a more gradual titration that reduces the incidence of ARIA-E by 41% at 24 weeks and by 35% at 52 weeks compared to the original dosing schedule. It should result in lower rates of ARIA-E without compromising Kisunla’s ability to reduce amyloid plaque or Kisunla’s once-monthly dosing. Eli Lilly will now offer patients and the care team confidence in the safety of Kisunla in reducing amyloid.

Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company that discovers, develops, manufactures, and sells human healthcare products. It specializes in a wide range of therapeutic areas, including diabetes, oncology, immunology, and neuroscience.

While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 11 Best Green Energy Penny Stocks to Buy Right Now and 10 Most Popular AI Penny Stocks to Buy According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.